Don’t market stem-cell products ahead of proof

Paolo Bianco ()
Additional contact information
Paolo Bianco: Paolo Bianco is a stem-cell biologist, and professor and director of anatomic pathology at Sapienza University of Rome, Italy. He is an editor of Stem Cell Research.

Nature, 2013, vol. 499, issue 7458, 255-255

Abstract: The controversy over an unproven stem-cell therapy in Italy highlights the dangers of doing translational medicine in reverse, argues Paolo Bianco.

Date: 2013
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/499255a Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:499:y:2013:i:7458:d:10.1038_499255a

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/499255a

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().